首页 | 本学科首页   官方微博 | 高级检索  
检索        

怡开治疗早期糖尿病肾病的临床观察
引用本文:王树国,刘艳.怡开治疗早期糖尿病肾病的临床观察[J].黑龙江医学,2005,29(10):747-748.
作者姓名:王树国  刘艳
作者单位:大庆市第四医院内分泌科,黑龙江,大庆,163000;吉林大学第一医院内分泌科,吉林,长春,130000
摘    要:目的观察怡开(TPK)对早期糖尿病肾病尿蛋白的影响。方法选取糖尿病早期肾病患者80例,随机分为治疗组(怡开组)40例,对照组(洛汀新组)40例。两组控制血糖、血压方法相同,对照组口服洛汀新10 mg,1次/d;治疗组口服怡开240 u,3次/d。两组疗程为3个月。结果和洛汀新组相比,怡开组治疗3个月后24 h尿微量白蛋白排泄率明显降低(P<0.05)。结论在早期糖尿病肾病阶段,短时间内口服怡开有较好降低尿微量白蛋白排泄率。

关 键 词:内科学  糖尿病肾病  微量白蛋白尿  怡开
文章编号:1004-5775(2005)10-0747-02
收稿时间:06 17 2005 12:00AM
修稿时间:2005年6月17日

Combination Therapy of TPK for Early Diabetic Nephropathy
WANG Shu-guo,LIU Yan.Combination Therapy of TPK for Early Diabetic Nephropathy[J].Heilongjiang Medical Journal,2005,29(10):747-748.
Authors:WANG Shu-guo  LIU Yan
Institution:Department of Endorinology, The 4th Hospital of Daqing City, Daqing 163000, China
Abstract:Objective To observe the effects of use of TPK on the treatment of early diabetic nephropathy.Methods 80 patients with early diabetic nephropathy were divided into the treatment group with TPK 240u tid for 3 months and the benazepril group with benazepril 10mg daily for 3 months.Results Compared with the benazepril group,proteinuria and albuminuria significantly decreased in the treatment group after 3 months therapy(P<0.05).Conclusion Administration of TPK may decrease proteinuria and albuminuria in early diabetic nephropathy in short term.
Keywords:diabetic nephropathy  Microalbuminuria  TPK
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号